Summary: <p>Heparin is the world’s ‘standard-of-care’ anticoagulant for the treatment of coronary syndromes. Not only is heparin recommended by all cardiac guidelines, it’s also the reference standard against which new anticoagulants are compared. The answer to whether or not heparin during coronary syndromes saves lives, or provides meaningful benefits, is the answer to the effectiveness and validity of present and future of acute coronary therapy. This month we found the root literature on heparin, and walked through the studies and their results. We have an answer.</p>
